BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Eisai's Fycompa Injection Approved in Japan, Paving the Way for Non-Oral Antiepileptic Treatment

Fycompa is a first-in-class AED discovered at Eisai’s Tsukuba Research Laboratories. The agent is a highly selective, noncompetitive AMPA receptor an...

January 20, 2024 | News

Canon Medical and Olympus Form Endoscopic Ultrasound Systems Alliance

Canon Medical has a history of more than 100 years in the diagnostic imaging systems business, including X-ray diagnostic systems, CT, MRI, and ultrasound ...

January 16, 2024 | News

Japan Approves Neurolief's Relivion®, Paving the Way for At-Home Migraine Treatment.

Relivion® is a novel, non-invasive multi-channel brain neuromodulation technology. It stands out by concurrently stimulating the occipital and tri...

January 12, 2024 | News

SyntheticGestalt and Enamine Partner for AI-Driven Drug Discovery Model

SyntheticGestalt, a research and development company specializing in the application of AI to the life sciences domain, and Enamine, the world's leading pr...

January 11, 2024 | News

AGC Biologics to Open New Manufacturing Site in Yokohama, Japan

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced plans to construct...

January 05, 2024 | News

Elpiscience, Astellas Ink Deal for Novel Bispecific Macrophage Engager

The two companies will collaboratively conduct early-stage research for these two programs. Elpiscience will also grant Astellas the right to add up ...

January 01, 2024 | News

AGC announces strategic expansion of its Biopharmaceutical CDMO capability in Yokohama, Japan, signaling a new era of innovation and growth

This expansion has been selected by the Japanese Ministry of Economy, Trade and Industry (METI) as part of its "Developing biopharmaceutical manufacturin...

December 26, 2023 | News

Astellas Completes Acquisition of Propella Therapeutics

Through the acquisition of Propella, Astellas has acquired PRL-02 (abiraterone decanoate), a next-generation androgen biosynthesis inhibitor being develope...

December 22, 2023 | News

Biocon Biologics Successfully Integrates Acquired Biosimilars Business Across 120 Countries

Biocon Biologics, a unique, fully integrated, global biosimilars company with a rich portfolio of insulins and monoclonal antibodies, has successfully conc...

December 19, 2023 | News

Fosun Pharma's Antimalarial Drug Trial Gets 500 Million Yen Boost from GHIT Fund for Global Accessibility Initiative

The Japan-based Global Health Innovative Technology Fund (GHIT Fund) announced that it will invest approximately US$3.3 million (approximate...

December 15, 2023 | News

Modalis and JCR Pharmaceuticals enter into joint research agreement

Modalis Therapeutics Corporation (Modalis) (Tokyo Stock Exchange: 4883) announced that it has entered into a joint research agreement with JCR Pharma...

December 14, 2023 | News

Fujitsu joins Japan Health & Productivity Management Alliance

To maintain and improve the physical and mental health of its employees, Fujitsu has been promoting various measures including awareness campaigns for canc...

December 11, 2023 | News

Whole Exome Sequencing Advancements in Unraveling Rare Diseases in Japan

The Rare Disease Diagnosis and Intractable Disease Research Center at Juntendo University has improved its diagnostic capabilities by combining research ...

December 11, 2023 | News

PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target

Collaboration focused on discovering oral inhibitors of protein-protein interaction (PPI) targets by leveraging PRISM BioLab's proprietary PepMetics®...

November 29, 2023 | News

Stay Connected